🇺🇸 FDA
Patent

US 9554987

Methods and formulations for treating sialic acid deficiencies

granted A61KA61K31/335A61K31/35

Quick answer

US patent 9554987 (Methods and formulations for treating sialic acid deficiencies) held by Ultragenyx Pharmaceutical Inc. expires Mon Jan 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Ultragenyx Pharmaceutical Inc.
Grant date
Tue Jan 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K31/335, A61K31/35, A61K31/7012, A61K9/0002